Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Mangoceuticals (NASDAQ:MGRX) Revolutionizing Men’s Health and Positioned for Robust Growth

Men's Health Market Size, Share, Growth, Revenue Outlook, Demand and Market Is Expected to Reach Highest CAGR of 15.00% forecast. Time to place Mangoceuticals (NASDAQ: MGRX) on top of your radar.

Mangoceuticals, Inc. (NASDAQ: MGRX), an innovative company dedicated to revolutionizing men’s health and wellness, is making waves in the market with its strategic developments and initiatives. The company’s focus on developing, marketing, and selling men’s health products via a secure telemedicine platform, including their standout medication, “Mango,” places them in a sizable and expanding industry.

The global market for men’s health is substantial and growing. Mangoceuticals is operating in an industry with substantial market potential.

MGRX is currently trading at $1.7, a contrast to its 52-week high of $4.37. Considering the recent company developments and the overall market growth, there is significant upside potential for this stock.

  1. Broadcast Exposure on “New To The Street”: Mangoceuticals is leveraging media outlets for greater visibility and market penetration. An in-depth interview with CEO Jacob Cohen on FMW Media’s “New To The Street” TV show provides potential investors, customers, and partners with valuable insights into the company’s strategies and future plans.
  2. Collaboration with Ice Shaker: The partnership with Ice Shaker enhances Mangoceuticals’ product portfolio and strengthens brand visibility. This move aligns with the company’s aggressive growth and branding strategy.
  3. “Make America Hard Again” Campaign and Website Launch: The launch of the “Make America Hard Again” nationwide marketing campaign and a new website demonstrates Mangoceuticals’ commitment to innovative marketing strategies. These initiatives contribute significantly to the company’s growth potential.
  4. Sponsorship Agreement with GaS Digital Network: Mangoceuticals’ partnership with the GaS Digital Network enhances the company’s reach to approximately 5 million listeners per month. This alliance showcases the company’s dynamic and targeted marketing strategy, helping it to reach potential customers in a broad array of niches.
  5. New Sponsor for Barstool Sports’ “Only Stans” Podcast: Sponsoring the “Only Stans” podcast aligns with Mangoceuticals’ strategic objective to penetrate highly engaged digital platforms, increasing its brand visibility and recognition.

Given the substantial size and growth prospects of the men’s health and wellness sector, combined with Mangoceuticals’ strategic initiatives, the company presents an attractive opportunity for investors. At its current trading price, significantly below its 52-week high, the stock holds notable upside potential. Watch MGRX closely as it continues to disrupt the market and revolutionize men’s health and wellness through key collaborations, innovative marketing initiatives, and a commitment to growth.

For more information on MGRX, click on the video below:



Video Link: https://www.youtube.com/embed/Dsjk51HjuJ8

Other notable biopharma stocks include Novo Nordisk (NYSE: NVO), Reata Pharmaceuticals (NASDAQ: RETA), Johnson & Johnson (NYSE: JNJ), Merck & Co (NYSE: MRK) and Novartis (NYSE: NVS), TEVA Pharmaceuticals (NYSE: TEVA).

Source 1: https://tinyurl.com/y8x8dy6m

Source 2: https://finance.yahoo.com/quote/MGRX/

Source 3: https://www.bloomberg.com/press-releases/2022-08-11/men-s-health-market-size-share-growth-revenue-outlook-demand-and-market-is-expected-to-reach-highest-cagr-of-15-00-forecast

 

 

Disclaimer: Please ensure to fully read and comprehend our disclaimer found at https://investorbrandmedia.com/disclaimer/. A payment of $4,500 was received by InvestorBrandMedia.com from Bullyzeye Media LLC for content distribution on MGRX, from 06/12/2023 to 07/15/2023. InvestorBrandMedia.com is neither an investment advisor nor a registered broker. No current owner, employee, or independent contractor of InvestorBrandMedia.com is registered as a securities broker-dealer, broker, investment advisor, or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. This article may contain forward-looking statements as defined under Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. These statements, often incorporating terms like "believes," "anticipates," "estimates," "expects," "projects," "intends," or similar expressions about future performance or conduct, are based on present expectations, estimates, and projections, and are not historical facts. They carry various risks and uncertainties that may result in significant deviation from the anticipated results or events. Past performance does not guarantee future results.InvestorBrandMedia.com does not commit to updating forward-looking statements based on new information or future events. Readers are encouraged to review all public SEC filings made by the profiled companies at https://www.sec.gov/edgar/searchedgar/companysearch. It is always important to conduct thorough due diligence and exercise caution in trading.InvestorBrandMedia.com is not managed by a licensed broker, a dealer, or a registered investment adviser. The content here is purely informational and should not be taken as investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor regarding forward-looking statements. Any statement that projects, foresees, expects, anticipates, estimates, believes, or understands certain actions to possibly occur are not historical facts and may be forward-looking statements. These statements are based on expectations, estimates, and projections that could cause actual results to differ greatly from those anticipated. Investing in micro-cap and growth securities is speculative and entails a high degree of risk, potentially leading to a total or substantial loss of investment. Please note that no content published here constitutes a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer or solicitation by InvestorBrandMedia.com or any third-party service provider to buy or sell securities or other financial instruments. The content in this article does not address the circumstances of any specific individual or entity and does not constitute professional and/or financial advice. InvestorBrandMedia.com is not a fiduciary by virtue of any person's use of or access to this content.

Media Contact
Company Name: Investor Brand Media
Contact Person: Ash K
Email: investorbrandmedia@gmail.com
Phone: (954) 593-5597
Country: United States
Website: https://investorbrandmedia.com/


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.